Tony Sk Mok

25PUBLICATIONS

168CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersLiquid biopsiesTe whaikaha me te Māori (Māori and disability)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (25)

Sort by Publication Date:

|Jun 24, 2026

Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

|Apr 10, 2026

First-Line Sacituzumab Govitecan Plus Pembrolizumab and Carboplatin in Metastatic Non-Small Cell Lung Cancer: Nonsquamous and Squamous Cohorts of the EVOKE-02 Study.

Jhanelle E Gray, Joel W Neal, Jyoti D Patel

|Mar 12, 2026

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Jian-Chun Duan, Jia Zhong, Bo-Yang Sun

|Feb 02, 2026

Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

Zhe Huang, Liang Zeng, Zhaohui Ruan

|Dec 08, 2025

Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood.

Yang Xia, Yin Zhu, Sai Zhang

|Apr 29, 2025

D3S-001 in advanced solid tumors with KRAS<sup>G12C</sup> mutations: a phase 1 trial.

Byoung Chul Cho, Shun Lu, Myung Ah Lee

Pageof 5

Frequent Collaborators

Yi-Long Wu

Byoung Chul Cho

Solange Peters

Benjamin J Solomon

Pilar Garrido

Yang Xia

Edward B Garon

Todd M Bauer

Keunchil Park

Martin Reck

Frequent Collaborators

Yi-Long Wu

Byoung Chul Cho

Solange Peters

Benjamin J Solomon